Response of immunocompromised children with solid tumors to a conjugate vaccine for Haemophilus influenzae type b.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 7931877.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Serum antibody response to a conjugated Haemophilus influenzae type b polyribosylribitol phosphate-diphtheria toxoid vaccine was assessed in nonvaccinated children aged 1 1/2 to 5 years receiving chemotherapy for solid tumors. Responses occurred in 21 (42%) of 50 children after first vaccination, and in 10 (45%) of 22 revaccinated children.
Medical subject headings
- Antibodies, Viral
- Diphtheria Toxoid
- Haemophilus Vaccines
- Haemophilus influenzae
- Immunocompromised Host
- Vaccines, Conjugate